From William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom (Q. Xiao, F.Z., S.Y.); Department of Cardiology, Peking University People's Hospital, Beijing, China (F.Z.); Department of Pharmacy, University of Naples Federico II, Naples, Italy (G.G., M. Maddaluno, P.M., A.I.); Cardiovascular Division, King's College London BHF Centre, London, United Kingdom (Y.H., Z.Z., Q. Xing, X.Y., M. Mayr, Q. Xu); Clemens Schöpf Institute, Technische Universität Darmstadt, Darmstadt, Germany (B.D., B.S.); Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom (P.M.).
Arterioscler Thromb Vasc Biol. 2014 Jan;34(1):90-8. doi: 10.1161/ATVBAHA.113.301418. Epub 2013 Oct 24.
We investigated the role of matrix metalloproteinase-8 (MMP8) in neointima formation and in vascular smooth muscle cell (VSMC) migration and proliferation.
After carotid artery wire injuring, MMP8(-/-)/apoE(-/-) mice had fewer proliferating cells in neointimal lesions and smaller lesion sizes. Ex vivo assays comparing VSMCs isolated from MMP8 knockout and wild-type mice showed that MMP8 knockout decreased proliferation and migration. Proteomics analysis revealed that a disintegrin and metalloproteinase domain-containing protein 10 (ADAM10) had lower concentrations in MMP8 knockout VSMC culture media than in MMP8 wild-type VSMC culture media. Western blot, flow cytometric, and immunocytochemical analyses showed that MMP8 knockout VSMCs contained more pro-ADAM10 but less mature ADAM10, more N-cadherin, and β-catenin in the plasma membrane but less β-catenin in the nucleus and less cyclin D1. Treatment of MMP8 wild-type VSMCs with an ADAM10 inhibitor, GI254023X, or siRNA knockdown of ADAM10 in MMP8 wild-type VSMCs inhibited proliferation and migration, increased N-cadherin and β-catenin in the plasma membrane, reduced β-catenin in the nucleus, and decreased cyclin D1 expression. Incubation of MMP8 knockout VSMCs with a recombinant ADAM10 rescued the proliferative and migratory ability of MMP8 knockout VSMCs and increased cyclin D1 expression. Furthermore, immunohistochemical analyses showed colocalization of ADAM10 with VSMCs and N-cadherin, and nuclear accumulation of β-catenin in the neointima in apoE(-/-)/MMP8(+/+) mice.
MMP8 enhances VSMC proliferation via an ADAM10, N-cadherin, and β-catenin-mediated pathway and plays an important role in neointima formation.
研究基质金属蛋白酶 8(MMP8)在新生内膜形成以及血管平滑肌细胞(VSMC)迁移和增殖中的作用。
颈总动脉线损伤后,MMP8(-/-)/apoE(-/-)小鼠的新生内膜病变中增殖细胞较少,病变较小。比较 MMP8 敲除和野生型小鼠分离的 VSMC 的离体实验表明,MMP8 敲除降低了增殖和迁移。蛋白质组学分析显示,MMP8 敲除 VSMC 培养基中的解整合素金属蛋白酶域蛋白 10(ADAM10)浓度低于 MMP8 野生型 VSMC 培养基。Western blot、流式细胞术和免疫细胞化学分析表明,MMP8 敲除 VSMC 含有更多的 pro-ADAM10 但成熟的 ADAM10 较少,质膜中 N-钙黏蛋白和β-连环蛋白较多,但核内β-连环蛋白较少,cyclin D1 较少。用 ADAM10 抑制剂 GI254023X 处理 MMP8 野生型 VSMC,或用 siRNA 敲低 MMP8 野生型 VSMC 中的 ADAM10,均可抑制增殖和迁移,增加质膜中的 N-钙黏蛋白和β-连环蛋白,减少核内β-连环蛋白,降低 cyclin D1 表达。用重组 ADAM10 孵育 MMP8 敲除 VSMC,可恢复 MMP8 敲除 VSMC 的增殖和迁移能力,并增加 cyclin D1 表达。此外,免疫组织化学分析显示 ADAM10 与 VSMC 和 N-钙黏蛋白的共定位,以及 apoE(-/-)/MMP8(+/+)小鼠新生内膜中β-连环蛋白的核内积聚。
MMP8 通过 ADAM10、N-钙黏蛋白和β-连环蛋白介导的途径增强 VSMC 增殖,并在新生内膜形成中发挥重要作用。